New York State Teachers Retirement System Sells 6,764 Shares of Humana Inc. (NYSE:HUM)

New York State Teachers Retirement System cut its position in shares of Humana Inc. (NYSE:HUM) by 6.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 101,201 shares of the insurance provider’s stock after selling 6,764 shares during the quarter. New York State Teachers Retirement System’s holdings in Humana were worth $25,676,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in HUM. Banque Pictet & Cie SA lifted its stake in Humana by 114.4% in the fourth quarter. Banque Pictet & Cie SA now owns 37,541 shares of the insurance provider’s stock worth $9,525,000 after purchasing an additional 20,031 shares during the last quarter. V Square Quantitative Management LLC raised its holdings in shares of Humana by 3.8% in the fourth quarter. V Square Quantitative Management LLC now owns 2,620 shares of the insurance provider’s stock worth $665,000 after buying an additional 96 shares during the period. Vontobel Holding Ltd. lifted its stake in shares of Humana by 36.5% during the 4th quarter. Vontobel Holding Ltd. now owns 5,365 shares of the insurance provider’s stock worth $1,361,000 after acquiring an additional 1,434 shares during the last quarter. Van ECK Associates Corp boosted its holdings in Humana by 151.4% during the 4th quarter. Van ECK Associates Corp now owns 3,366 shares of the insurance provider’s stock valued at $854,000 after acquiring an additional 2,027 shares during the period. Finally, Savant Capital LLC grew its position in Humana by 1.9% in the 4th quarter. Savant Capital LLC now owns 3,327 shares of the insurance provider’s stock valued at $844,000 after acquiring an additional 63 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.32% of the company’s stock.

Humana Price Performance

Shares of NYSE HUM opened at $253.61 on Friday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a market cap of $30.54 billion, a PE ratio of 22.46, a P/E/G ratio of 2.11 and a beta of 0.56. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The business has a 50-day simple moving average of $271.27 and a two-hundred day simple moving average of $294.21.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities analysts expect that Humana Inc. will post 16.11 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Piper Sandler lifted their target price on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Royal Bank of Canada restated an “outperform” rating and issued a $283.00 target price on shares of Humana in a research note on Wednesday. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $290.00 price target on shares of Humana in a research note on Wednesday. Truist Financial increased their price objective on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Finally, Morgan Stanley lowered their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $293.05.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.